The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs
- PMID: 15288922
- DOI: 10.1016/j.vetmic.2004.05.006
The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs
Abstract
Two experiments were conducted to investigate if virus shedding could be reduced following a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccination (KV) of PRRSV infected pigs. In experiment 1, PRRSV infected pigs were vaccinated with KV on days 14 and 28 following infection. Viremia and serum neutralizing (SN) antibody were compared to infected pigs with no KV. The second experiment was conducted in an identical manner. In addition to viremia and SN antibody, virus in oropharyngeal scrapings and interferon gamma (IFN-gamma) producing cells were monitored. Magnitude and duration of viremia were not different between KV vaccinated and non-vaccinated groups. No virus was detected in oropharyngeal scraping from any pig, nor was there a difference in the detection of viral RNA. In both experiments, however, increases in SN titer and number of IFN-gamma producing cells were observed. The SN titer was significantly higher in KV vaccinated groups than in non-vaccinated group on days 42 and 42-56 following infection in experiments 1 and 2, respectively. The number of IFN-gamma producing cells was slightly higher in KV vaccinated groups than in non-vaccinated group on days 42 and 63. These observations suggest that KV had no effect on virus shedding. However, previously infected pigs responded immunologically to KV, as demonstrated by increases in SN antibody titers and IFN-gamma producing cells.
Similar articles
-
Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.Vaccine. 2009 Jun 8;27(28):3788-99. doi: 10.1016/j.vaccine.2009.03.028. Epub 2009 Apr 3. Vaccine. 2009. PMID: 19442420
-
Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):99-115. doi: 10.1016/j.vetimm.2005.07.026. Epub 2005 Sep 13. Vet Immunol Immunopathol. 2006. PMID: 16165219 Clinical Trial.
-
Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):151-60. doi: 10.1016/j.vetimm.2005.08.015. Epub 2005 Sep 12. Vet Immunol Immunopathol. 2006. PMID: 16162362
-
Adjuvants for porcine reproductive and respiratory syndrome virus vaccines.Vet Immunol Immunopathol. 2009 May 15;129(1-2):1-13. doi: 10.1016/j.vetimm.2008.12.018. Epub 2008 Dec 11. Vet Immunol Immunopathol. 2009. PMID: 19157569 Review.
-
Porcine reproductive and respiratory syndrome virus (PRRSV) in serum and oral fluid samples from individual boars: will oral fluid replace serum for PRRSV surveillance?Virus Res. 2010 Dec;154(1-2):170-6. doi: 10.1016/j.virusres.2010.07.025. Epub 2010 Jul 27. Virus Res. 2010. PMID: 20670665 Review.
Cited by
-
Intranasal delivery of inactivated PRRSV loaded cationic nanoparticles coupled with enterotoxin subunit B induces PRRSV-specific immune responses in pigs.Sci Rep. 2022 Mar 8;12(1):3725. doi: 10.1038/s41598-022-07680-9. Sci Rep. 2022. PMID: 35260663 Free PMC article.
-
Recent Advances in Porcine Reproductive and Respiratory Syndrome Virus NADC30-Like Research in China: Molecular Characterization, Pathogenicity, and Control.Front Microbiol. 2022 Jan 11;12:791313. doi: 10.3389/fmicb.2021.791313. eCollection 2021. Front Microbiol. 2022. PMID: 35087492 Free PMC article. Review.
-
Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.BMC Vet Res. 2012 Oct 3;8:182. doi: 10.1186/1746-6148-8-182. BMC Vet Res. 2012. PMID: 23031319 Free PMC article. Clinical Trial.
-
The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.PLoS Pathog. 2010 Jan 15;6(1):e1000730. doi: 10.1371/journal.ppat.1000730. PLoS Pathog. 2010. PMID: 20084110 Free PMC article.
-
Histopathological Pulmonary Lesions in 1st-Day Newborn Piglets Derived from PRRSV-1 MLV Vaccinated Sows at the Last Stage of Gestation.Life (Basel). 2023 Jul 23;13(7):1609. doi: 10.3390/life13071609. Life (Basel). 2023. PMID: 37511984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical